GSK Plc (GSK)
50.73
+0.48
(+0.96%)
USD |
NYSE |
Sep 01, 09:58
GSK Net Income (TTM) : 7.078B for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 7.078B |
| March 31, 2026 | 8.534B |
| December 31, 2025 | 8.287B |
| September 30, 2025 | 7.962B |
| June 30, 2025 | 5.156B |
| March 31, 2025 | 4.603B |
| December 31, 2024 | 3.743B |
| September 30, 2024 | 3.594B |
| June 30, 2024 | 5.451B |
| March 31, 2024 | 5.990B |
| December 31, 2023 | 6.601B |
| September 30, 2023 | 8.013B |
| June 30, 2023 | 6.988B |
| March 31, 2023 | 5.740B |
| December 31, 2022 | 6.133B |
| September 30, 2022 | 4.793B |
| June 30, 2022 | 5.180B |
| March 31, 2022 | 6.021B |
| December 31, 2021 | 5.384B |
| September 30, 2021 | 5.925B |
| June 30, 2021 | 6.469B |
| March 31, 2021 | 7.721B |
| December 31, 2020 | 8.129B |
| September 30, 2020 | 8.973B |
| June 30, 2020 | 9.241B |
| Date | Value |
|---|---|
| March 31, 2020 | 7.562B |
| December 31, 2019 | 6.699B |
| September 30, 2019 | 6.420B |
| June 30, 2019 | 6.275B |
| March 31, 2019 | 5.571B |
| December 31, 2018 | 5.345B |
| September 30, 2018 | 3.191B |
| June 30, 2018 | 3.045B |
| March 31, 2018 | 2.290B |
| December 31, 2017 | 2.749B |
| September 30, 2017 | 3.622B |
| June 30, 2017 | 2.958B |
| March 31, 2017 | 2.370B |
| December 31, 2016 | 1.353B |
| September 30, 2016 | 312.54M |
| June 30, 2016 | 146.23M |
| March 31, 2016 | 1.022B |
| December 31, 2015 | 12.67B |
| September 30, 2015 | 14.94B |
| June 30, 2015 | 14.58B |
| March 31, 2015 | 15.59B |
| December 31, 2014 | 4.643B |
| September 30, 2014 | 7.113B |
| June 30, 2014 | 8.040B |
| March 31, 2014 | 8.517B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| AstraZeneca PLC | 10.40B |
| Eli Lilly & Co. | 26.71B |
| Merck & Co., Inc. | 3.169B |
| Pfizer Inc. | 4.373B |
| Sanofi | 4.656B |